Skip to main content
. 2023 Aug 25;25(9):euad226. doi: 10.1093/europace/euad226

Figure 3.

Figure 3

Proposed approach to patients with CIED-detected AHREs according to the 2020 ESC Guidelines14 (with permission). AF, atrial fibrillation; AHRE, atrial high-rate episode; OAC, oral anticoagulant; SCAF, subclinical atrial fibrillation; CIED, cardiac-implanted electrical device; CHA2DS2-VASc, Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, Stroke, Vascular disease, Age 65–74 years, Sex category (female).